Lataa...
Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney
Thiazolidinediones (TZDs), known as peroxisome proliferator-activated receptor (PPAR) agonists, are used to treat type 2 diabetes. However, ∼5% of patients experience the treatment-limiting side effect of edema. Studies have implicated activation of the epithelial sodium channel (ENaC) as a cause of...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Physiological Society
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353644/ https://ncbi.nlm.nih.gov/pubmed/22169011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00306.2011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|